Disaster Risk Reduction

A new report released by the White House warns that climate change is an imminent and growing threat to public health, and that extreme heat will kill around 27,000 US residents per year by 2100.

A science advisor to the Obama administration by the name of John Holdren commented on the report at a recent press conference, noting that extreme heat waves will make outdoor work periodically “impossible:”

“People who work outdoors will be unable to control their body temperature and will die. This is a really, really big deal.”

April 8 — The Environmental Protection Agency has issued aguidance document clarifying the claims disinfectant makers can and can't make during outbreaks of emerging pathogens.

The guidance is meant to prevent some of the confusion that occurred during the recent Ebola outbreak, when some cleaning industry companies were unsure if they could legally market their products as being effective at killing the virus.

It also creates a way around the EPA's rule preventing companies from making claims that their product can kill a specific microbe without lab studies on that specific microbe. In the case of many new or emerging pathogens, such as Ebola or avian influenza, efficacy tests in a lab could be infeasible or even dangerous.

After being declared Ebola-free months ago, Senegal is still relentless in controlling any possible outbreak of the Ebola virus in its country.

With a dozen tents and twelve beds surrounded by a double fence, an Ebola emergency treatment centre has been built in the Fann Hospital in Dakar to contain the virus in case it penetrates the country’s porous borders,RFI reports.

The centre, a partnership between the government, Red Cross and the Japanese cooperation, will also be used for outbreaks associated with other infectious diseases.

For more than a month in 2015, a multidisciplinary team including infectious disease and critical care physicians and nurses, respiratory therapists and other specialists at the National Institutes of Health (NIH) treated a critically ill patient who had contracted Ebola virus disease in Sierra Leone. A new report by the medical caregivers details the clinical course of the 34-year-old American healthcare worker who was admitted to the NIH Special Clinical Studies Unit on day 7 of his illness. The patient survived his illness with intensive supportive care, despite multi-organ failure.

Upon admission to the NIH Clinical Center, the patient was enrolled in a clinical trial and was randomly assigned to receive optimized supportive care only. The trial's other arm included treatment with experimental therapies. In the first few days after admission, the patient's condition worsened dramatically and he experienced sequential organ failure, despite intensive supportive care that included maintenance of optimal fluid and electrolyte balances. His prognosis was poor.